Rational Strategy for Designing Peptidomimetic Small Molecules Based on Cyclic Peptides Targeting Protein-Protein Interaction between CTLA-4 and B7-1.
Quick Facts
What This Study Found
Generated small-molecule compounds with IC50 values in the single-digit μM range against CTLA-4.
Key Numbers
How They Did This
The study utilized ribosomal display to identify inhibitory cyclic peptides, followed by conversion to small molecules using PepMetics® scaffolds.
Why This Research Matters
Targeting protein-protein interactions is crucial for developing effective therapies. This new strategy could streamline the design of small-molecule drugs, making them more accessible.
What This Study Doesn't Tell Us
The study primarily focuses on in vitro results, which may not directly translate to in vivo efficacy in humans.
Trust & Context
- Original Title:
- Rational Strategy for Designing Peptidomimetic Small Molecules Based on Cyclic Peptides Targeting Protein-Protein Interaction between CTLA-4 and B7-1.
- Published In:
- Pharmaceuticals (Basel, Switzerland), 15(12) (2022)
- Authors:
- Tsuihiji, Kumiko, Honda, Eiji, Kojoh, Kanehisa, Katoh, Shizue, Taguri, Tomonori, Yoshimori, Atsushi, Takashima, Hajime
- Database ID:
- RPEP-06550
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06550APA
Tsuihiji, Kumiko; Honda, Eiji; Kojoh, Kanehisa; Katoh, Shizue; Taguri, Tomonori; Yoshimori, Atsushi; Takashima, Hajime. (2022). Rational Strategy for Designing Peptidomimetic Small Molecules Based on Cyclic Peptides Targeting Protein-Protein Interaction between CTLA-4 and B7-1.. Pharmaceuticals (Basel, Switzerland), 15(12). https://doi.org/10.3390/ph15121506
MLA
Tsuihiji, Kumiko, et al. "Rational Strategy for Designing Peptidomimetic Small Molecules Based on Cyclic Peptides Targeting Protein-Protein Interaction between CTLA-4 and B7-1.." Pharmaceuticals (Basel, 2022. https://doi.org/10.3390/ph15121506
RethinkPeptides
RethinkPeptides Research Database. "Rational Strategy for Designing Peptidomimetic Small Molecul..." RPEP-06550. Retrieved from https://rethinkpeptides.com/research/tsuihiji-2022-rational-strategy-for-designing
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.